| scholarly article | Q13442814 |
| P356 | DOI | 10.1189/JLB.0109046 |
| P698 | PubMed publication ID | 19487306 |
| P2093 | author name string | Consuelo Ortega | |
| Ignacio J Molina | |||
| Manuel Santamaría | |||
| Pilar Romero | |||
| José C Moreno | |||
| Juan M Carrillo | |||
| Silvia Fernández-A | |||
| P2860 | cites work | Cyclosporine A inhibits IL-15-induced IL-17 production in CD4+ T cells via down-regulation of PI3K/Akt and NF-kappaB. | Q38507718 |
| Resolution of psoriasis upon blockade of IL-15 biological activity in a xenograft mouse model | Q40156550 | ||
| The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells | Q41687602 | ||
| Psoriasis is characterized by accumulation of immunostimulatory and Th1/Th17 cell-polarizing myeloid dendritic cells | Q41860308 | ||
| Human interleukin 17-producing cells originate from a CD161+CD4+ T cell precursor. | Q42417394 | ||
| Serum levels of IL-17 and IL-22 are reduced by etanercept, but not by acitretin, in patients with psoriasis: a randomized-controlled trial | Q46397390 | ||
| Memory effector (CD45RO+) and cytotoxic (CD8+) T cells appear early in the margin zone of spreading psoriatic lesions in contrast to cells expressing natural killer receptors, which appear late | Q47588197 | ||
| Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. | Q50793292 | ||
| Alpha1beta1 integrin is crucial for accumulation of epidermal T cells and the development of psoriasis. | Q51974034 | ||
| In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin. | Q51985338 | ||
| IL-23 up-regulates IL-10 and induces IL-17 synthesis by polyclonally activated naive T cells in human. | Q51994829 | ||
| Up-regulation of macrophage inflammatory protein-3 alpha/CCL20 and CC chemokine receptor 6 in psoriasis. | Q52026606 | ||
| Inhibition of keratinocyte apoptosis by IL-15: a new parameter in the pathogenesis of psoriasis? | Q52970666 | ||
| TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function | Q24314628 | ||
| The IL-23/Th(17) axis: therapeutic targets for autoimmune inflammation | Q28266133 | ||
| T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma | Q28506783 | ||
| Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation | Q29614840 | ||
| Phenotypic and functional features of human Th17 cells | Q29619323 | ||
| IL-17 family cytokines and the expanding diversity of effector T cell lineages | Q29619361 | ||
| Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis | Q29620506 | ||
| Role for NKG2-A and NKG2-C surface receptors in chronic CD4+ T-cell responses | Q34369055 | ||
| The majority of epidermal T cells in Psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiat | Q34505900 | ||
| Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia. | Q36229379 | ||
| Getting under the skin: the immunogenetics of psoriasis | Q36247085 | ||
| Innate and adaptive immunity and the pathophysiology of psoriasis | Q36400854 | ||
| Pathogenesis and therapy of psoriasis | Q36742020 | ||
| Interleukin-17 in inflammatory skin disorders | Q36943488 | ||
| Explaining phenotype heterogeneity in patients with psoriasis | Q37019141 | ||
| Autoimmunity in dry eye is due to resistance of Th17 to Treg suppression | Q37071969 | ||
| Induction of IL-17+ T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis | Q37179608 | ||
| P433 | issue | 2 | |
| P921 | main subject | cytotoxicity | Q246181 |
| P304 | page(s) | 435-443 | |
| P577 | publication date | 2009-08-01 | |
| P1433 | published in | Journal of Leukocyte Biology | Q1524048 |
| P1476 | title | IL-17-producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines. | |
| P478 | volume | 86 |
| Q38237063 | Brodalumab: an evidence-based review of its potential in the treatment of moderate-to-severe psoriasis |
| Q36980670 | CCR6 as a possible therapeutic target in psoriasis |
| Q30428781 | CD4+ and CD8+ T cell- and IL-17-mediated protection against Entamoeba histolytica induced by a recombinant vaccine |
| Q34611308 | CD57 expression and cytokine production by T cells in lesional and unaffected skin from patients with psoriasis |
| Q58235912 | CD8 T Cells and IFN-γ Emerge as Critical Players for Psoriasis in a Novel Model of Mouse Psoriasiform Skin Inflammation |
| Q33866441 | CD8 positive T cells express IL-17 in patients with chronic obstructive pulmonary disease |
| Q38852309 | CD8(+) T cells in human autoimmune arthritis: the unusual suspects |
| Q36625142 | CD8(+) T cells mediate RAS-induced psoriasis-like skin inflammation through IFN-γ |
| Q35758889 | CD8+ T cells induce thyroid epithelial cell hyperplasia and fibrosis |
| Q82661651 | CXCL16 and CXCR6 are upregulated in psoriasis and mediate cutaneous recruitment of human CD8+ T cells |
| Q38231403 | Cellular sources of IL-17 in psoriasis: a paradigm shift? |
| Q54394197 | Characterization of gliadin-specific Th17 cells from the mucosa of celiac disease patients. |
| Q38144211 | Chemokine receptors in psoriasis |
| Q43022569 | Childhood psoriasis: a study of 137 cases from central China |
| Q37352741 | Compartmentalized and systemic control of tissue immunity by commensals |
| Q33936619 | Compromised gastrointestinal integrity in pigtail macaques is associated with increased microbial translocation, immune activation, and IL-17 production in the absence of SIV infection |
| Q37313736 | Contribution of CD8 T lymphocytes to the immuno-pathogenesis of multiple sclerosis and its animal models. |
| Q38553845 | Contribution of the IL-17 Pathway to Psoriasis and Psoriatic Arthritis |
| Q39028574 | Cytokines IL-17 and IL-22 in the host response to infection |
| Q28255491 | Cytokines in psoriasis |
| Q27334358 | Cytotoxic T cells mediate pathology and metastasis in cutaneous leishmaniasis |
| Q54274575 | Different frequencies of Tc17/Tc1 and Th17/Th1 cells in chronic spontaneous urticaria. |
| Q29391765 | Differential Frequency of CD8+ T Cell Subsets in Multiple Sclerosis Patients with Various Clinical Patterns |
| Q58785143 | Distinguishing rheumatoid arthritis from psoriatic arthritis |
| Q64066277 | Distribution of Functional CD4 and CD8 T cell Subsets in Blood and Rectal Mucosal Tissues |
| Q34380190 | Divergent gene activation in peripheral blood and tissues of patients with rheumatoid arthritis, psoriatic arthritis and psoriasis following infliximab therapy |
| Q48244963 | Dust mite induces multiple polar T cell axes in human skin |
| Q33923351 | Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus |
| Q39966021 | Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes |
| Q64102310 | Effector Functions of CD4+ T Cells at the Site of Local Autoimmune Inflammation-Lessons From Rheumatoid Arthritis |
| Q36373858 | Effector T-cell subsets in systemic lupus erythematosus: update focusing on Th17 cells |
| Q39792098 | Endogenous interleukin-22 protects against inflammatory bowel disease but not autoimmune cholangitis in dominant negative form of transforming growth factor beta receptor type II mice |
| Q35105666 | Engagement of NKG2D on bystander memory CD8 T cells promotes increased immunopathology following Leishmania major infection |
| Q36414419 | Epitope-specific CD8+ T cells play a differential pathogenic role in the development of a viral disease model for multiple sclerosis |
| Q56967563 | Expression of IL-17F is associated with non-pathogenic Th17 cells |
| Q44890278 | Gene-gene interactions in IL23/Th17 pathway contribute to psoriasis susceptibility in Chinese Han population |
| Q34254490 | Host defense mechanisms in secondary syphilitic lesions: a role for IFN-gamma-/IL-17-producing CD8+ T cells? |
| Q34456152 | Humanized mouse model of skin inflammation is characterized by disturbed keratinocyte differentiation and influx of IL-17A producing T cells |
| Q38498941 | IL-17 downregulates filaggrin and affects keratinocyte expression of genes associated with cellular adhesion |
| Q36807407 | IL-17 in psoriasis: implications for therapy and cardiovascular co-morbidities |
| Q61651896 | IL-17 in the immunopathogenesis of spondyloarthritis |
| Q35108924 | IL-17 induces an expanded range of downstream genes in reconstituted human epidermis model |
| Q38138107 | IL-17 producing T cells in celiac disease: angels or devils? |
| Q38111443 | IL-17 targeted therapies for psoriasis |
| Q38833064 | IL-17+ CD8+ T cells: Differentiation, phenotype and role in inflammatory disease |
| Q38081171 | IL-22, not simply a Th17 cytokine |
| Q26830943 | IL-23/IL-17A Dysfunction Phenotypes Inform Possible Clinical Effects from Anti-IL-17A Therapies |
| Q35779110 | IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist |
| Q34059557 | Immune activation is associated with CD8 T cell interleukin-21 production in HIV-1-infected individuals |
| Q26995800 | Immunology of psoriasis |
| Q51603409 | Immunophenotyping of T cells in the peripheral circulation in psoriasis. |
| Q41865300 | In vitro induced CD8+ regulatory T cells inhibit skin inflammation |
| Q47824146 | Increased Th22 cells are independently associated with Th17 cells in type 1 diabetes. |
| Q36484115 | Increased expression of interleukin-17 pathway genes in nonlesional skin of moderate-to-severe psoriasis vulgaris |
| Q33815062 | Increasing a robust antigen-specific cytotoxic T lymphocyte response by FMDV DNA vaccination with IL-9 expressing construct. |
| Q30589228 | Inflammation and mechanical stretch promote aortic stiffening in hypertension through activation of p38 mitogen-activated protein kinase. |
| Q37921634 | Innate immunity in the pathogenesis of psoriasis. |
| Q28298644 | Integrative responses to IL-17 and TNF-α in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis |
| Q34181184 | Interferon-β exacerbates Th17-mediated inflammatory disease |
| Q38379864 | Interleukin-17 antagonists in the treatment of psoriasis |
| Q34154244 | Interleukin-17+CD8+ T cells are enriched in the joints of patients with psoriatic arthritis and correlate with disease activity and joint damage progression |
| Q36826339 | Interleukin-21 overexpression dominates T cell response to Epstein-Barr virus in a fatal case of X-linked lymphoproliferative syndrome type 1 |
| Q24629567 | Interleukin-21-producing HIV-1-specific CD8 T cells are preferentially seen in elite controllers |
| Q34388287 | Interleukin-21: a multifunctional regulator of immunity to infections |
| Q34551370 | Intestinal T-cell responses in celiac disease - impact of celiac disease associated bacteria |
| Q24626968 | Lifting the silver flakes: the pathogenesis and management of chronic plaque psoriasis |
| Q90733175 | Loss of TIPE2 Has Opposing Effects on the Pathogenesis of Autoimmune Diseases |
| Q38040302 | MODULATING CO-STIMULATION DURING ANTIGEN PRESENTATION TO ENHANCE CANCER IMMUNOTHERAPY. |
| Q39417348 | Mustard seed (Sinapis Alba Linn) attenuates imiquimod-induced psoriasiform inflammation of BALB/c mice |
| Q34043846 | New insights of T cells in the pathogenesis of psoriasis |
| Q58724084 | Novel Concepts in Psoriatic Arthritis Management: Can We Treat to Target? |
| Q47859049 | Old and New Biological Therapies for Psoriasis. |
| Q26751101 | Periodontal Systemic Connections-Novel Associations-A Review of the Evidence with Implications for Medical Practitioners |
| Q34426538 | Periodontal disease and risk of psoriasis among nurses in the United States |
| Q36797792 | Peripheral Tc17 and Tc17/Interferon-γ Cells are Increased and Associated with Lung Function in Patients with Chronic Obstructive Pulmonary Disease |
| Q47097758 | Pharmacological inhibition of RORγt suppresses the Th17 pathway and alleviates arthritis in vivo. |
| Q58235909 | Psoriasis |
| Q34495706 | Psoriasis and the MAITing game: a role for IL-17A+ invariant TCR CD8+ T cells in psoriasis? |
| Q37789387 | Psoriasis: from pathogenesis to novel therapeutic approaches |
| Q38020227 | Psoriasis: rationale for targeting interleukin-17. |
| Q64925719 | RNA-seq and flow-cytometry of conventional, scalp, and palmoplantar psoriasis reveal shared and distinct molecular pathways. |
| Q53033887 | Rationale for the development of speckled hyperpigmentation in the areas of psoriatic plaques after treatment with biologic agents. |
| Q26800988 | Regulation of Dendritic Cell Function in Inflammation |
| Q59798737 | Resident-Memory T Cells in Tissue-Restricted Immune Responses: For Better or Worse? |
| Q90103308 | Role of IL-17A in Chronic Rhinosinusitis With Nasal Polyp |
| Q38190986 | Role of IL-23 in the pathogenesis of psoriasis: a novel potential therapeutic target? |
| Q38991358 | Roles of microRNAs in psoriasis: Immunological functions and potential biomarkers |
| Q48278167 | Scanning the Immunopathogenesis of Psoriasis |
| Q46453213 | Secukinumab, a fully human anti-interleukin-17A monoclonal antibody, exhibits minimal immunogenicity in patients with moderate-to-severe plaque psoriasis |
| Q37138974 | Secukinumab, a novel anti-IL-17A antibody, shows low immunogenicity potential in human in vitro assays comparable to other marketed biotherapeutics with low clinical immunogenicity |
| Q55512008 | T Cell Hierarchy in the Pathogenesis of Psoriasis and Associated Cardiovascular Comorbidities. |
| Q28069848 | T Helper Cell Subsets in Clinical Manifestations of Psoriasis |
| Q38042048 | Targeting the Th17 pathway in psoriasis |
| Q34856750 | Tc17 CD8 T cells: functional plasticity and subset diversity. |
| Q35093526 | Tc17 cells in patients with uterine cervical cancer |
| Q88110812 | The IL-17A-producing CD8+ T-cell population in psoriatic lesional skin comprises mucosa-associated invariant T cells and conventional T cells |
| Q64063151 | The Number of Donor-Specific IL-21 Producing Cells Before and After Transplantation Predicts Kidney Graft Rejection |
| Q42860267 | The Role of Etanercept on the Expression of Markers of T Helper 17 Cells and Their Precursors in Skin Lesions of Patients with Psoriasis Vulgaris |
| Q52337140 | The current status, challenges, and future developments of new tuberculosis vaccines. |
| Q24623195 | The emerging role of IL-17 in the pathogenesis of psoriasis: preclinical and clinical findings |
| Q33640627 | The immunologic effects of estrogen on psoriasis: A comprehensive review |
| Q91664106 | The role of IL-17A in axial spondyloarthritis and psoriatic arthritis: recent advances and controversies |
| Q38184626 | The role of innate and lymphoid IL-22-producing cells in the immunopathology of primary Sjögren's syndrome. |
| Q38217029 | The role of interleukin-17A in psoriatic disease |
| Q38349779 | Tofacitinib for the treatment of moderate-to-severe psoriasis |
| Q55709454 | Typhus Group Rickettsiosis, Germany, 2010-20171. |
| Q58544217 | Understanding psoriasis: Role of miRNAs |
| Q27304934 | Use of praziquantel as an adjuvant enhances protection and Tc-17 responses to killed H5N1 virus vaccine in mice |
| Q52883792 | [Expression and role of Tc17 cells in mice with neutrophilic asthma]. |
| Q35141744 | β2-Adrenergic agonists bias TLR-2 and NOD2 activated dendritic cells towards inducing an IL-17 immune response |
Search more.